EBS - Emergent BioSolutions Inc

-

$undefined

N/A

(N/A)

Emergent BioSolutions Inc NEW YORK STOCK EXCHANGE INC.:EBS Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through their specialty products and contract development and manufacturing services, the company is dedicated to providing solutions that address public health threats. Through social responsibility, Emergent BioSolutions aims to build healthier and safer communities. The company aspires to deliver peace of mind to theis patients and customers so they can focus on what's most important in their lives. In working together, Emergent envisions protecting or enhancing 1 billion lives by 2030.

Location: 400 Professional Dr Ste 400, Maryland, 20879-3457, US | Website: www.emergentbiosolutions.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

1.08B

Cash

149.9M

Avg Qtr Burn

N/A

Short % of Float

13.43%

Insider Ownership

2.10%

Institutional Own.

59.52%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Update

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Approved

Quarterly sales

Phase 1

Update

CHIKV VLP Details
Chikungunya, Viral infection

Failed

Discontinued

Failed

Discontinued

Failed

Discontinued